2010 Guidelines Part 13: Pediatric BLS Writing Group Disclosures

Writing Group Member Employment Research Grant Other Research Support Speakers’ Bureau/Honoraria Ownership Interest Consultant/ Advisory Board Other
Marc D. Berg University of Arizona/University Physician’s Healthcare (UPH)– Associate Professor of Clinical Pediatrics and Member, Board
of Directors
None None None None None None
Stephen M. Schexnayder University of Arkansas for Medical Sciences—Professor/ Division Chief; AHA Compensated Consultant as Associate Senior Science
Editor.
*Pharmacokinetics of Proton Pump Inhibitors None *Contemporary Forums None None
Leon Chameides Emeritus Director Pediatric Cardiology, Connecticut Children’s Medical Center Clinical Professor, University of Connecticut None None None None None None
Mark Terry Johnson County Med-Act–Deputy Chief Operations None None None None None None
Aaron Donoghue University of Pennsylvania–Assistant Professor of Pediatrics None None None None None None
Robert W. Hickey University of Pittsburgh—MD Salary support on NIH grant to investigate the role of cylcopentenone prostaglandins in hypoxic-ischemic brain injury None None None None
Robert A. Berg University of Pennsylvania Professor None None None None None None
Robert M. Sutton The Children’s Hospital of Philadelphia–Critical Care Attending None None None None None None
Mary Fran Hazinski Vanderbilt University School of Nursing—Professor; AHA ECC Product Development—Senior Science Editor. Significant compensation from the AHA to provide protected time to edit, review, write for the development of the 2010 AHA
Guidelines for CPR and ECC and the 2010 International Liaison Committee on Resuscitation Consensus on CPR and ECC Science
with Treatment Recommendation
None None None None None None
  • This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts
    of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and
    submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period,
    or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity,
    or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less
    than “significant” under the preceding definition.

  • * Modest.

  • Significant.